Левомицетина таблетки

Quick links

Choose a section

Quick links to important sections

Advertisements

Левомицетина таблетки

Advertisements
Advertisements

Overview of Левомицетина таблетки

Quick Facts

Property Description
Active ingredient Chloramphenicol (Хлорамфеникол)
Form Tablets (таблетки), oral dosage form
Pharmacological class Antibiotic (Amphenicol class)
Common use Systemic bacterial infections
Origin Synthetic

Левомицетина таблетки: What Type of Medicine is It?

Левомицетина таблетки is a potent, prescription-only antimicrobial medication containing the active substance Chloramphenicol. It is fundamentally classified as an antibiotic and belongs to the amphenicol class of antimicrobials. This compound is recognized as a broad-spectrum agent, meaning it exhibits activity against a wide variety of bacterial pathogens, including Gram-positive and Gram-negative organisms.

The primary purpose of this medication is to help the body effectively stop the growth and spread of serious, systemic bacterial infections. Because of its potency and unique mechanism, Chloramphenicol is clinically recognized as an essential option for specific severe or complex infections that may not respond to other, more commonly used antibiotics.

Composition, Origin, and Dosage Form

The active ingredient within these tablets is Chloramphenicol (Хлорамфеникол). While the substance was historically isolated from the bacterium Streptomyces venezuelae, it is now produced synthetically for medical use. The preparation, Левомицетина таблетки, represents the oral dosage form, typically as a film-coated tablet for convenient ingestion.

This tablet form is intended for systemic route of administration, allowing the Chloramphenicol to be absorbed from the gastrointestinal tract into the bloodstream to reach the site of internal infection. Chloramphenicol works by inhibiting protein synthesis in bacteria, thereby suppressing their ability to reproduce. This action directly supports the drug's general therapeutic goal of controlling the infectious process.

Advertisements

What side effects are possible with Левомицетина таблетки?

Possible side effects and safety information

The safety profile of Chloramphenicol (Левомицетина таблетки) is characterized by the potential for serious blood disorders, restricting its regulatory use to severe infections where less hazardous treatments are deemed ineffective. The officially documented adverse reactions are categorized across several physiological systems.


Hematological and Systemic Safety Patterns

The most critical safety domain involves the Blood and Lymphatic System. Reactions include two distinct types of bone marrow toxicity: a dose-related, reversible depression that typically resolves upon discontinuation, and a rare, irreversible aplastic anemia that is not dose-dependent and can be fatal. This severe reaction has been reported to occur weeks or months after therapy is stopped.

System-Organ Class Examples of Documented Adverse Reactions
Blood and Lymphatic System Aplastic anemia, bone marrow depression, thrombocytopenia
Nervous System Optic neuritis (may lead to vision loss, often with long-term use), peripheral neuritis, headache
Gastrointestinal Nausea, vomiting, diarrhea, glossitis (low incidence)

Serious and Population-Specific Considerations

A specific, life-threatening risk for newborn and premature infants is the Gray Syndrome, a potentially fatal condition involving circulatory collapse. The onset of symptoms typically appears 2 to 9 days following the initiation of high-dose therapy in this sensitive population. Additionally, patients with hepatic impairment may have an increased risk of adverse effects due to the drug’s metabolism. For all patients, regulatory documents stipulate that adequate blood studies must be performed during treatment, reinforcing the focus on hematological safety.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with chloramphenicol (the active ingredient in Левомицетина) can lead to serious and potentially fatal systemic toxicity. Official regulatory documents specifically detail the clinical manifestations associated with excessive drug levels and identify populations at the highest risk.

Documented Overdose Symptoms

Symptoms of acute toxicity include gastrointestinal issues such as nausea and vomiting, and more severe systemic effects like abdominal distension, hypotension, and hypothermia. Progressive effects can lead to metabolic acidosis, cardiovascular collapse, and coma.

Urgent Medical Attention

Immediate emergency medical help is required upon observing signs of systemic toxicity, particularly in infants and young children. For this population, high drug levels can cause a life-threatening condition known as “gray syndrome.”

“Gray Syndrome” Risk

This specific toxic reaction is seen primarily in newborns, premature infants, and infants, linked to the immature ability to metabolize and excrete the drug. Symptoms of "gray syndrome" progress rapidly, typically starting with abdominal distension, followed by pallid cyanosis, vasomotor collapse, and potentially death within hours. Any signs of a bloated stomach, drowsiness, gray or ashen skin color, low body temperature, or unresponsiveness must trigger an immediate call for emergency medical services.

Advertisements

Therapeutic Uses of Левомицетина таблетки

What Левомицетина Таблетки Treats: Main Uses and Benefits

Левомицетина (Chloramphenicol) is considered relevant for managing specific, critical bacterial diseases, including conditions associated with acute or disruptive episodes, such as serious enteric fevers. This medication is used for serious infections when other antibiotics cannot be utilized. It contributes to supporting the management of the bacterial burden and assists with maintaining stability when standard, less potent therapies are ineffective or unavailable.

This medicine is commonly used to help with symptoms related to heightened physiological activity and severe discomfort, including persistent high fever, systemic distress, and symptoms of increased neurological or muscular activity. This application is strategically reserved for complex clinical scenarios where the causative bacteria are resistant to common first-line treatments or when the infection has failed to respond to initial therapy. It offers a relevant therapeutic option when symptoms become temporarily overwhelming.


Quick Fact: Support for Symptoms that Create Noticeable Physiological Strain

Focus Description
Primary Use Context Applied in clinical settings that involve acute or unstable symptom patterns due to specific severe bacterial conditions.
Symptom Focus Helps address symptom clusters that may become intense or disruptive, such as persistent fever and systemic distress.
Patient Benefit Provides support that helps ease the overall symptom burden during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Левомицетина Таблетки?

Eligibility for systemic use of Левомицетина (Chloramphenicol) is strictly defined by regulatory guidelines due to its potency and potential for serious adverse effects, and is reserved for specific, severe bacterial infections.

Contraindications and Prohibited Use

The following populations are officially contraindicated and must not use this medicine:

  • Individuals with a known Hypersensitivity (allergy) to Chloramphenicol or any components of the tablet.
  • Patients with a history of Aplastic Anemia or other documented severe blood dyscrasias.
  • The medicine is prohibited for use in minor infections, viral diseases, or for bacterial prophylaxis (prevention).
  • Breastfeeding women are contraindicated due to the risk to the infant.

Populations Requiring Conditional or Restricted Use

Use is permitted only under strict monitoring and often with dosage adjustments for the following groups:

  • Neonates (Infants under 4 weeks of age): Use is highly restricted and requires extreme caution and mandatory therapeutic drug monitoring due to the risk of “Gray Syndrome.”
  • Patients with Hepatic or Renal Impairment: Eligibility is conditional upon the implementation of reduced dosage and close monitoring of drug serum concentration.
  • Pregnant Women: Use is generally not recommended, with specific caution warranted during the third trimester due to potential newborn risk.
Advertisements

What should I know about interactions with other medicines?

Левомицетина (Chloramphenicol) has a well-defined interaction profile in regulatory documents, structured around metabolic inhibition and additive toxicity risk.

Contraindicated and Additive Toxicity

Co-administration with other medicinal products known to cause bone marrow depression is formally documented as contraindicated by regulatory authorities. This restriction addresses the high risk of additive pharmacodynamic toxicity, specifically severe hematologic events. Official interaction summaries also note an interaction risk with live bacterial vaccines and require caution in patients with preexisting blood dyscrasias, making them highly vulnerable to these risks.

Metabolic Enzyme Inhibition and Exposure

The drug is officially documented as a potent inhibitor of Cytochrome P450 enzymes CYP2C19 and CYP3A4. This inhibition is the basis for most pharmacokinetic interactions. The resulting reduced clearance leads to a documented increase in the systemic exposure of co-administered drugs. For instance, co-administration with Warfarin is known to significantly increase its anticoagulant effect, and the clearance of medications such as Phenytoin and Cyclosporine is officially shown to be reduced, causing elevated plasma concentrations. Furthermore, official summaries classify an interaction with the supplement Red yeast rice as a serious risk.

Advertisements

Mechanism of Action

Targeted Inhibition of Bacterial Protein Manufacturing

The core action of Левомицетина таблетки (Chloramphenicol) is its precise binding to the 50S ribosomal subunit of susceptible bacteria . This molecular interaction acts as an inhibitor, specifically blocking the peptidyl transferase enzyme and preventing the formation of new peptide bonds. This immediate arrest of protein synthesis places the entire bacterial population in a state of bacteriostasis, preventing growth and multiplication.

Functional Consequence: Arrest of Pathogen Proliferation

By eliminating the pathogen's ability to create essential structural and metabolic proteins, the drug rapidly halts the proliferation of the bacterial population. This physiological arrest enables the host's natural immune defenses to engage and clear the suppressed bacterial population, resulting in a systemic effect of limiting bacterial proliferation and an indirect reduction in the stimulus for the host's inflammatory response.

Mechanistic Limitations and Off-Target Interaction

A key constraint of this mechanism is its off-target interaction with the 70S-like ribosomes found in the mitochondria of human cells, particularly in rapidly dividing tissues like bone marrow. Furthermore, the mechanism is constrained by bacterial resistance, such as enzymatic inactivation by Chloramphenicol acetyltransferase (CAT), which prevents the drug from reaching its ribosomal target.

Advertisements

Dosage and Administration Information

How to Use Левомицетина Таблетки

The administration of Левомицетина таблетки (Chloramphenicol) is structured according to precise instructions, ensuring consistent and appropriate use. The preparation is an oral dosage form, intended for systemic delivery via the mouth.

Dosing and Frequency Guidelines

The standard adult regimen is typically 50 mg per kilogram of body mass daily (50 mg/kg/day), which is administered in four equally divided doses at 6-hour intervals. For severe infections, the initial daily dose may be temporarily increased up to 100 mg/kg for the first 24 to 48 hours, but this elevated dose must be reduced to the standard 50 mg/kg/day as soon as clinically practical.

Administration Detail Official Principle
Administration Route Oral (tablet form)
Standard Daily Dose 50 mg/kg in divided doses
Maximum Daily Dose Generally not to exceed 4 g
Frequency Every 6 hours (four times daily)

Administration Conditions and Adjustments

The tablets are best taken on an empty stomach, such as one hour before or two hours after a meal, with a full glass of water. Completing the full course of treatment prescribed is a required procedural step.

Dose adjustments are mandatory for certain populations. Patients with hepatic impairment (liver disease) require a dose reduction due to the drug’s primary metabolism pathway. For pediatric patients, the typical dose is 50 mg/kg daily, administered in divided doses; however, neonates require a specific lower initial dose of 25 mg/kg daily. The protocol often requires Therapeutic Drug Monitoring (TDM) to measure drug concentration in the bloodstream when treatment extends beyond 48 hours, guiding any necessary dose modifications.

Advertisements

Recent Clinical Evidence

Evidence Related to Severe Systemic Infections (e.g., Typhoid Fever)

Levomycetin tablets was studied for use in conditions characterized by periods of heightened symptoms, such as typhoid fever and other serious bacterial infections. Research examined outcomes related to systemic or functional imbalance, and research parameters measured over defined time intervals. Observational studies describe recorded changes in symptoms among observed patient groups during specific study periods.

The findings describe patterns observed in the studies relevant to the observation of these acute episodes. However, the sample sizes in the relevant studies were modest. Certainty remains low regarding long-term results, as follow-up durations were limited in many cases. Comparative evidence is lacking against other antibacterial drugs.


Evidence Related to Other Types of Bacterial Infections

Studies explored Levomycetin in relation to other indications where symptoms may vary in intensity, such as certain respiratory or urinary tract infections caused by susceptible bacteria. Studies monitored outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort. Data show patterns related to short-term changes in symptom intensity. However, evidence is limited for these other indications, and the evidence quality varies across studies. Findings were mixed, and the existing research provides context but not individual predictions for these uses.


Long-Term Studies, Special Populations, and Uncertainties

Research examined observational settings evaluating daily-life functioning following defined treatment intervals, but there is limited information for long-term outcomes, and the sustainability of possible changes that may appear is not fully established.

Research was also evaluated in special populations, including children and individuals with co-morbid conditions. The findings indicate that the results apply only to the specific populations studied, and data for certain subgroups remain insufficient, with follow-up durations being limited.

Evidence highlights what is known — and what is still uncertain regarding Levomycetin. Certainty remains low because the quality of available data may vary. Study results reflect the specific conditions under which they were conducted and research does not determine whether an individual will respond similarly.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Левомицетина таблетки (FAQ)


Q: How long does it take for Levomycetin tablets to start working?

Regulatory information indicates that the active substance, Chloramphenicol, is absorbed rapidly into the bloodstream after a dose is taken by mouth. Pharmacokinetic data generally describes that the maximum concentration of the drug in the blood is often reached within one hour of administration.


Q: How long is Levomycetin tablets usually taken?

Regulatory documents describe that the duration of treatment is determined by a healthcare provider based on the type and severity of the infection being treated. Official instructions outline the requirement to complete the full prescribed course of treatment, which is typically a minimum of 7 to 10 days for many serious bacterial infections, though it may be adjusted.


Q: Can alcohol be consumed while taking Levomycetin?

Specific patient information often describes that alcohol consumption is generally permitted with systemic Chloramphenicol. Given the serious nature of the drug and the conditions it treats, it is important to consult the specific leaflet or product information provided with the prescribed medicine.


Q: How is Levomycetin eliminated from the body?

According to official pharmacokinetic data, the active ingredient is primarily processed and broken down (metabolized) in the liver. The breakdown products are then mainly removed from the body through the kidneys in the urine. The rate of elimination is described as potentially slower in individuals with hepatic (liver) impairment.


Q: Can Levomycetin be taken if there was a previous reaction to penicillin?

Official contraindications state that the medicine is not suitable for individuals with a known hypersensitivity (allergy) to Chloramphenicol itself. Chloramphenicol is chemically distinct from penicillin, and core regulatory documents do not consistently list a previous reaction to penicillin as a formal contraindication.


Q: What studies confirm the effectiveness of Levomycetin?

Official regulatory documents define the approved use of the drug for specific serious bacterial infections, such as typhoid fever. This is supported by its established mechanism—inhibiting bacterial protein synthesis—and clinical data showing recorded changes in symptoms among patient groups treated in studies.


Q: Can Levomycetin affect blood test results?

Yes. Due to the drug's safety profile, regulatory documents state that routine complete blood count (CBC) tests are necessary to monitor patients during treatment. This is because the drug has the potential to affect blood cell production, which can alter the results of these tests.


Q: How do Levomycetin tablets differ from other antibiotics?

The key difference described in official documents is its unique mechanism of action. It specifically binds to the bacterial 50S ribosomal subunit, which prevents the bacteria from manufacturing the essential proteins they need to grow and multiply. This molecular mechanism is distinct from many other classes of antibiotics.


Q: Can Levomycetin tablets be taken for flu or ARVI?

Official documentation states that the medicine is strictly prohibited for use in minor infections or diseases caused by viruses, as listed in the contraindications. Viral illnesses like the flu or common cold (ARVI) are not indications for this antibiotic.


Q: If a dose of Levomycetin is missed, what should be done?

Official patient guidelines describe that if a dose is missed, the instruction is to take it as soon as possible when remembered. If it is already close to the time for the next scheduled dose, the missed dose should be skipped entirely. The guidance is to avoid taking a double dose to compensate for the missed one.


Q: Is a prescription needed to buy Levomycetin tablets?

Yes, official labeling classifies Левомицетина таблетки as a potent, prescription-only medication. This classification means that dispensing the drug requires a prescription from a licensed healthcare provider.


Q: Do Levomycetin tablets affect the effectiveness of birth control pills?

Official drug interaction summaries note that Chloramphenicol may potentially reduce the effectiveness of birth control medications that contain estrogen. The need to discuss this potential interaction with a healthcare provider is generally noted in regulatory information.


Q: Can bacteria develop resistance to Levomycetin?

Yes, bacterial resistance to Chloramphenicol is documented in regulatory and scientific literature. The most common resistance mechanism described is the production of an enzyme called Chloramphenicol acetyltransferase (CAT), which inactivates the drug.


Q: What should be done if signs of an allergy to Levomycetin appear?

Official patient information describes that signs associated with a severe allergic reaction, such as a rash, swelling, or difficulty breathing, are conditions requiring immediate medical evaluation. A known hypersensitivity to the drug is a formal contraindication for use.


Q: Can Levomycetin be stopped if one feels better?

Regulatory instructions emphasize the requirement to complete the full course of treatment as prescribed by the healthcare provider. Official guidelines indicate that stopping the medicine prematurely carries a risk of not fully clearing the targeted infection.


Q: Why is Levomycetin sometimes prescribed for eye infections?

The active substance, Chloramphenicol, is approved and used in non-oral forms, such as eye drops or ointments, for treating superficial bacterial eye infections. This is due to its documented efficacy against susceptible bacteria and its ability to penetrate ocular tissue.


Q: What should be done in case of Levomycetin overdose?

Official medical information states that a suspected overdose is a situation requiring rapid medical evaluation and supportive care. Overdose management may involve monitoring the drug's concentration in the bloodstream (Therapeutic Drug Monitoring).


Q: Are there restrictions on the timing of Levomycetin intake (before/after meals)?

Official administration instructions suggest that the tablets are best taken on an empty stomach. This timing is typically described as one hour before eating a meal or waiting two hours after a meal, and taking the dose with a full glass of water.


Q: What factors can affect the effectiveness of Levomycetin?

Factors described in regulatory sources that can influence the drug’s effectiveness include the presence of bacterial resistance, concurrent use of certain enzyme-inducing medicines that speed up its metabolism, and necessary dosage reduction due to hepatic (liver) impairment.


Q: Does Levomycetin produced by different companies differ?

The core requirement across all manufacturers is that the tablets must contain the exact same active ingredient, Chloramphenicol, in the stated quantity to meet regulatory standards. However, the inactive components (excipients) used to form the tablet may differ between various manufacturers.


Q: What intestinal infections are treated with Levomycetin?

Official documentation notes that Chloramphenicol is used for serious systemic bacterial infections, including conditions such as typhoid fever. These types of serious infections are known to involve the gastrointestinal tract.


Q: Is it true that Levomycetin can be toxic?

Regulatory warnings indicate that the drug carries the potential for toxicity, particularly characterized by the risk of severe hematological adverse effects (blood disorders). For this reason, its use is restricted to serious infections where less risky treatments are not effective.


Q: Does Levomycetin interact with dietary supplements or vitamins?

Official interaction summaries explicitly classify a serious risk of interaction with the supplement Red yeast rice. Interaction summaries also note a risk with live bacterial vaccines, which some people may use as supplements.

Advertisements

How should Левомицетина таблетки be stored and disposed of?

How to Store and Dispose of Левомицетина таблетки

Storage and disposal of Левомицетина tablets (Chloramphenicol) must follow the specific conditions mandated by regulatory authorities to ensure product stability and safety.

Official Storage Requirements

  • Temperature: Store the tablets below 30 C (some labeling specifies 15 C to 30 C) and keep from freezing.
  • Protection: The product must be stored in a dry, closed container and protected from light, heat, and moisture.
  • Child Safety: The medicine must be kept out of the reach of children.
  • Stability: The typical labeled shelf life is 36 months; outdated medicine must be discarded.

Disposal Protocol

Unused or expired tablets should be disposed of via community drug take-back programs as the preferred method. If a program is unavailable, official guidance recommends mixing the medicine with an undesirable substance (e.g., coffee grounds) and placing it in a sealed container before discarding it in the household trash. The tablets must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Левомицетина таблетки found in:

A-Z Index: